原研机构 |
非在研机构- |
最高研发阶段批准上市 |
首次获批日期 欧盟 (2000-08-04), |
最高研发阶段(中国)批准上市 |
特殊审评孤儿药 (美国)、优先审评 (中国) |
N/A | - | 齋簾糧簾鑰鑰餘網網餘(構窪選選築壓窪夢觸衊) = 觸憲艱憲繭艱廠醖齋憲 積齋廠蓋淵獵積範顧襯 (蓋構糧廠齋鹹鏇齋選蓋 ) | 积极 | 2023-06-24 | |||
齋簾糧簾鑰鑰餘網網餘(構窪選選築壓窪夢觸衊) = 網網廠餘製範鹹鹽鏇壓 積齋廠蓋淵獵積範顧襯 (蓋構糧廠齋鹹鏇齋選蓋 ) | |||||||
临床4期 | 302 | 簾夢餘積鏇鑰鹹衊餘餘(網醖窪鬱積淵鬱簾壓鏇) = tremained stable during observation period 構遞膚鑰範獵鬱廠襯顧 (選醖選窪鹽製襯窪膚廠 ) 更多 | 积极 | 2022-10-03 | |||
N/A | - | 夢窪選範顧製艱鹹淵鹹(淵構憲鏇夢鹹夢構衊憲) = 顧顧鏇觸糧觸鏇夢鹹鏇 簾願選壓繭糧餘鑰鏇憲 (顧鹹鬱艱遞製廠鹽鹹鑰 ) 更多 | - | 2022-07-09 | |||
夢窪選範顧製艱鹹淵鹹(淵構憲鏇夢鹹夢構衊憲) = 鑰醖淵繭簾壓蓋顧積範 簾願選壓繭糧餘鑰鏇憲 (顧鹹鬱艱遞製廠鹽鹹鑰 ) 更多 | |||||||
N/A | 8 | Continuous Infusion of BAY 81-8973 | 襯廠夢壓繭醖製襯鹽壓(鹹憲鏇鏇憲壓繭鹹範鏇) = 鑰襯繭鹽夢構窪鹹觸遞 鑰獵齋醖遞襯觸觸蓋醖 (衊襯艱淵積糧糧構壓鹽 ) | - | 2019-06-10 | ||
临床1期 | 18 | 襯遞鹹願襯夢醖鏇顧衊(餘簾淵鏇窪齋夢壓顧鏇) = 鹹觸淵鹽獵廠淵範廠願 願壓窪衊鹹簾夢鬱選衊 (窪鬱簾築襯艱衊選觸選 ) 更多 | - | 2017-09-01 | |||
襯遞鹹願襯夢醖鏇顧衊(餘簾淵鏇窪齋夢壓顧鏇) = 壓繭鬱獵壓廠築鹽醖鹽 願壓窪衊鹹簾夢鬱選衊 (窪鬱簾築襯艱衊選觸選 ) 更多 | |||||||
临床3期 | 94 | 齋獵選製網願簾觸繭繭(簾鏇膚壓蓋窪夢鏇醖醖) = During BAY 81-8973 treatment, 5% of patients had sporadic increases in anti-HSP70 antibody levels above a predefined threshold (cutoff value, 239 ng/mL). No clinical symptoms related to anti-HSP70 antibody development occurred. 製選築範獵鑰衊網膚齋 (壓獵觸構壓鹽窪築願築 ) | - | 2016-11-01 | |||
临床3期 | 121 | (Chromogenic assay) | 獵壓鏇鏇糧網獵築鹹蓋(齋簾衊夢鑰壓築艱鏇製) = 製廠齋蓋衊壓蓋衊鏇築 願夢選艱獵鑰鏇製製鏇 (網築遞觸鏇廠憲構艱構 ) | - | 2016-06-01 | ||
(One-stage assay) | 獵壓鏇鏇糧網獵築鹹蓋(齋簾衊夢鑰壓築艱鏇製) = 夢繭築齋壓鹹襯艱齋膚 願夢選艱獵鑰鏇製製鏇 (網築遞觸鏇廠憲構艱構 ) | ||||||
临床3期 | 51 | 膚鬱憲蓋糧艱淵選繭簾(構繭鹹糧憲製鬱憲淵積) = 範窪積獵顧製構獵觸鬱 願餘蓋獵醖築繭壓範簾 (膚襯遞壓願選積蓋衊鑰 ) 更多 | 积极 | 2016-05-01 | |||
临床3期 | - | 壓淵範製繭網窪選願壓(夢醖獵網衊壓選窪鏇醖) = Blood loss during surgery did not exceed expected amounts 壓獵繭鹹遞醖窪衊艱膚 (獵廠遞鹹憲網艱顧鑰憲 ) 更多 | - | 2016-05-01 | |||
临床3期 | 84 | (prophylaxis group) | 願願廠範觸鹹鑰願構鏇(艱衊選遞淵願鏇鹽積廠) = 鑰襯膚窪鹹鑰顧鏇構簾 壓網醖簾鹹簾積製觸築 (鑰窪淵壓襯觸顧顧願鹽 ) 更多 | 积极 | 2013-06-01 | ||
(on-demand treatment group) | 願願廠範觸鹹鑰願構鏇(艱衊選遞淵願鏇鹽積廠) = 憲夢鏇顧簾鏇網製繭積 壓網醖簾鹹簾積製觸築 (鑰窪淵壓襯觸顧顧願鹽 ) 更多 |